- Home
- ALOT vs IMA Comparison
ALOT vs IMA Comparison
Compare ALOT & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALOT | IMA |
|---|---|---|
| Founded | 1969 | 2019 |
| Country | United States | United States |
| Employees | N/A | 15 |
| Industry | Computer peripheral equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 65.3M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALOT | IMA |
|---|---|---|
| Price | $8.62 | $5.91 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 14.2K | ★ 29.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $151,283,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.16 | N/A |
| 52 Week Low | $6.96 | $5.70 |
| 52 Week High | $12.68 | $17.50 |
Technical Indicators
Market Signals| Indicator | ALOT | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 38.71 | 36.74 |
| Support Level | $8.63 | N/A |
| Resistance Level | $8.79 | $7.17 |
| Average True Range (ATR) | 0.21 | 0.33 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 23.53 | 7.89 |
Price Performance
Historical ComparisonAbout ALOT AstroNova Inc.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.